The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.
Open accessAbstract
Metallothionein (MT) may provide protection against doxorubicin-induced heart damage. To test this hypothesis, a heart-specific promoter was used to drive the expression of human MT-IIa gene in transgenic mice. Four healthy transgenic mouse lines were produced. Cardiac MT was constitutively overexpressed from 10- to 130-fold higher than normal. The MT concentration was not altered in liver, kidneys, lungs, or skeletal muscles. Other antioxidant components including glutathione, glutathione peroxidase, glutathione reductase, catalase, and superoxide dismutase were not altered in the MT-overexpressing heart. Mice (7-wk-old) from transgenic lines expressing MT activity 10- or 130-fold higher than normal and from nontransgenic controls were treated intraperitoneally with doxorubicin at a single dose of 20 mg/kg, and were killed on the 4th day after treatment. As compared to normal controls, transgenic mice exhibited a significant resistance to in vivo doxorubicin-induced cardiac morphological changes, and the increase in serum creatine phosphokinase activity. Atria isolated from transgenic mice and treated with doxorubicin in tissue bath was also more resistant to functional damage induced by this drug. The results provide direct evidence for the role of MT in cardioprotection against doxorubicin toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aebi, H. (1984) · Methods in Enzymology · doi:10.1016/s0076-6879(84)05016-3 · Cited by 25,696
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482 · cited 1×
“Specific activity is expressed as m mol H 2 O 2 /min per mg of protein (19).”
BackgroundTietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,047
[12] Assays of glutathione peroxidase
Flohé, L., & Günzler, W. A. (1984) · Methods in Enzymology · doi:10.1016/s0076-6879(84)05015-1 · Cited by 4,951
Carlberg, I., & Mannervik, B. (1985) · Methods in Enzymology · doi:10.1016/s0076-6879(85)13062-4 · Cited by 3,000
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Hamer, D. H. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.004405 · Cited by 1,800
Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., & Young, R. C. (1977) · Science · doi:10.1126/science.877547 · Cited by 1,111
Thornalley, P. J., & Vašák, M. (1985) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(85)90098-6 · Cited by 1,033
A general mechanism for microsomal activation of quinone anticancer agents to free radicals.
Bachur, N. R., Gordon, S. L., & Gee, M. V. (1978) · PubMed · Cited by 722
FVB/N: an inbred mouse strain preferable for transgenic analyses.
Taketo, M., Schroeder, A. C., Mobraaten, L. E., Gunning, K. B., Hanten, G., Fox, R. R., Roderick, T. H., Stewart, C. L., Lilly, F., & Hansen, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2065 · Cited by 598
Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90088-j · Cited by 517
Karin, M., & Richards, R. I. (1982) · Nature · doi:10.1038/299797a0 · Cited by 452
Isolation and characterization of the mouse cardiac myosin heavy chain genes
Gulick, J., Subramaniam, A., Neumann, J., & Robbins, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31568-0 · Cited by 330
Kang, Y. J., Chen, Y., & Epstein, P. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12610 · Cited by 303
Self-citationEarly and delayed clinical cardiotoxicity of doxorubicin
Buzdar, A. U., Marcus, C., Blumenschein, G. R., & Smith, T. L. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2761::aid-cncr2820551206>3.0.co;2-p · Cited by 300
Nebot, C., Moutet, M., Huet, P., Xu, J. Z., Yadan, J. C., & Chaudiere, J. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1521 · Cited by 269
Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins
Thomas, J. P., Bachowski, G. J., & Girotti, A. W. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90195-9 · Cited by 241
Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
Ferrans, V. J. (1978) · PubMed · Cited by 219
Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stress
Olson, R. D., Boerth, R. C., Gerber, J. G., & Nies, A. S. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90001-1 · Cited by 211
Metallothioneins and Cell Death by Anticancer Drugs
Lazo, J. S., & Pitt, B. R. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003223 · Cited by 123
Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals
Lee, V., Randhawa, A. K., & Singal, P. K. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.4.h989 · Cited by 113
An electron spin resonance study of the reduction of peroxides by anthracycline semiquinones
Kalyanaraman, B., Sealy, R. C., & Sinha, B. K. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90270-8 · Cited by 90
Julicher, R. H. M., van der Laarse, A., Sterrenberg, L., van Treslong, C. H. F. B., Bast, A., & Noordhoek, J. (1985) · PubMed · Cited by 28
Powell, S. R., & McCay, P. B. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90078-6 · Cited by 24
Cited by
METALLOTHIONEIN: An Intracellular Protein to Protect Against Cadmium Toxicity
Klaassen, C. D., Liu, J., & Choudhuri, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.267 · Cited by 1,169
Hyperglycemia-Induced Apoptosis in Mouse Myocardium
Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y., & Kang, Y. J. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1938 · Cited by 662
Self-citationDoxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21280 · Cited by 569
Drug-induced mitochondrial dysfunction and cardiotoxicity
Varga, Z. V., Ferdinandy, P., Liaudet, L., & Pacher, P. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2015 · Cited by 531
Adriamycin-induced oxidative mitochondrial cardiotoxicity
Berthiaume, J. M., & Wallace, K. B. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0140-y · Cited by 409
Metadata
- Authors
- Kang, Y. J., Chen, Y., Yu, A., Voss-McCowan, M., & Epstein, P. N.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-09-15
- Volume
- 100
- Issue
- 6
- Pages
- 1501-1506
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2025223586
- Cited by
- 253
- References
- 25
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.